Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality

Annals of the Rheumatic Diseases(2025)10.1016/j.ard.2025.11.007Source: DataRank Database

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality is a research paper published in Annals of the Rheumatic Diseases (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.

N/A

0.165DataRank · unranked

Scored on demand from live citation data

2 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 1.65)OA: closedTopics (23)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.165

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (43)

Éric Boilard ORCID,Emmanuelle Rollet‐Labelle ORCID,Christian Lood ORCID,Anne‐Sophie Julien ORCID,Michał Abrahamowicz ORCID

Live enrichment

PubMed:41390302 OpenAlex:https://openalex.org/W4417292326

National Institutes of Health

Grant: 1 R21 AR079542

National Institutes of Health

Grant: 1 R21 AR077565

National Institutes of Health

Grant: 1 R01 HL158606

Ministry of Education

Grant: NRF-2021R1A6A1A03038899

Canadian Institutes of Health Research

Grant: MOP-88526

Canadian Institutes of Health Research

Grant: MOP-57752

Canadian Institutes of Health Research

Grant: MOP-86526

Santé

National Research Foundation of Korea

FWCI

1.65

Citation Percentile

0.9%

Citation Trend

2026

closedLicense: https://www.elsevier.com/legal/tdmrep-license

publisherhttps://api.elsevier.com/content/article/PII:S0003496725045339?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0003496725045339?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ard.2025.11.007

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41390302

repositoryhttps://pure.qub.ac.uk/en/publications/60ae242a-fa57-43cf-9319-cffa81141d4f

Fields of Study

Systemic Lupus Erythematosus ResearchRenal Transplantation Outcomes and TreatmentsVasculitis and related conditions

MeSH Terms

AdultAutoantibodiesDNA, MitochondrialFemaleHumansLupus Erythematosus, SystemicLupus NephritisMaleMiddle AgedMitochondriaPrognosisBiomarkersProportional Hazards Models

Keywords

AntibodyConnective tissue diseaseLupus erythematosusAutoantibodyRheumatoid arthritisSystemic lupus erythematosusRheumatology

Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality

FAIR Checklist

DataRank Breakdown

Authors (43)

Funding (9 grants)

Impact

Open Access

Topics